Building public health capacity for antimicrobial resistance

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Investments to combat antimicrobial resistance are working, but more work is needed, emphasized by the COVID-19 pandemic. The United States must continue to invest in preparing public health systems across One Health to address threats from multiple angles, simultaneously, and across One Health.
  
  Addressing Antimicrobial Resistance and Health Equity
  
  Health equity is when everyone has the opportunity to be as healthy as possible. Many risks for antimicrobial- resistant infections are tied to social determinants of health—where people live, how often people engage with health care, quality of care received, and other factors. CDC is addressing health equity related to antimicrobial resistance as a part of CDC’s CORE Initiative, an agency- wide strategy to increase equity across public health.
  
  Publication date from document properties.
  
  COVID19-Impacts-AR-summary-508.pdf
  
  
• Subjects:
  Coronavirus Infections COVID-19 Drug Resistance, Microbial Health Equity
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Fact Sheet
• Pages in Document:
  2 unnumbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:c8f2a870dc51f046249e212e42ecadc03408e6423ef32ba54a283be5d6a90143
• Download URL:
  https://stacks.cdc.gov/view/cdc/119022/cdc_119022_DS1.pdf
• File Type:
  [PDF - 749.25 KB ]